Advanced search
Publication Cover
Acta Cardiologica Volume 74, 2019 - Issue 1
Submit an article Journal homepage
1,257
Views
21
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Age at death of major cardiovascular diseases in 13 cohorts. The seven countries study of cardiovascular diseases 45-year follow-up

Alessandro MenottiAssociation for Cardiac Research, Rome, Italy;
,
Paolo Emilio PudduEA 4650, Signalisation, électrophysiologie et imagerie des lésions d’ischémie reperfusion myocardique, Normandy University, Caen, France; ;Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, Sapienza University of Rome, Rome, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6191-7838
ORCID Icon,
Hanna TolonenDepartment of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland;
,
Hisashi AdachiDepartment of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University, School of Medicine, Kurume, Japan;
,
Anthony KafatosDepartment of Social Medicine, Preventive Medicine and Nutrition Clinic, University of Crete, Heraklion, Greece;
&
Daan KromhoutDepartement of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Pages 66-72 | Received 08 Feb 2018, Accepted 11 Mar 2018, Published online: 23 Mar 2018

References

  • Canudas-Romo V. The modal age at death and the shifting mortality hypothesis. Demog Res 2008;19:1179–1204.
  • Tuljapurkar S. The final inequality variance in age at death. In: Shoven JB, editor. Demography and the economy, from the Natinal Bureau of Economic Research. Chicago: University of Chicago Press; 2010. p. 209–221.
  • Wrycza TF, Missov TI, Baudisch A. Quantifying the shape of aging. PLoS One. 2015; 10:e0119163.
  • Horiuchi S, Ouellette N, Cheung SLK, et al. Modal age at death: lifespan indicator in the era of longevity extension. Vienna Yearbook of Population Res. 2013; 2:37–69.
  • Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years’ observations on male British doctors. Br Med J. 2004; 328:1519–1531.
  • Tielemans SM, Geleijnse JM, Menotti A, et al. Ten-year blood pressure trajectories, cardiovascular mortalty and life years lost in two extinction cohorts: the Minnesota Business and Professional Men and the Zutphen Study. J Am Heart Assoc. 2015;4:001378.
  • Keys A, Blackburn H, Menotti A. Coronary heart disease in seven countries. Circulation. 1970;41(Suppl 1):1–211.
  • Keys A, Aravanis C, Blackburn H, et al. Seven countries study. A multivariate analysis of death and coronary heart disease. Cambridge (MA): Harvard Univ Press; 1980. p. 1–381.
  • Kromhout D, Menotti A, Blackburn H. Prevention of Coronary Heart Disease. Diet, Lifestyle and Risk Factors in the Seven Countries Study. Norwell (MA): Kluwer Publ; 2002. p. 1–267.
  • World Health Organization. International Classification of Diseases. 8th Rev ed. Geneva: World Health Organization; 1975.
  • Menotti A, Puddu PE, Lanti M, et al. Epidemiology of typical coronary heart disease versus heart disease of uncertain etiology (atypical) fatalities and their relationships with classic coronary risk factors. Int J Cardiol. 2013;168:3963–3967.
  • Puddu PE, Terradura Vagnarelli O, Mancini M, et al. Typical and atypical coronary heart disease deaths and their different relationships with risk factors. The Gubbio residential cohort Study. Int J Cardiol. 2014;173:300–304.
  • Rose G, Blackburn H. Cardiovascular Survey Methods. Geneva: World Health Organization; 1968.
  • Anderson JT, Keys A. Cholesterol in serum and lipoprotein fractions; its measurement and stability. Clin Chem. 1956; 2:145–159.
  • Puddu PE, Piras P, Menotti A. Competing risks and lifetime coronary heart disease incidence during 50 years of follow-up. Int J Cardiol. 2016; 219:79–83.
  • Puddu PE, Piras P, Menotti A. Lifetime competing risks between coronary heart disease mortality and other causes of death during 50 years of follow-up. Int J Cardiol. 2017;228:359–363.
  • Menotti A, Puddu PE, Adachi H, et al. The strength of the multivariable associations of major risk factors predicting coronary heart disease mortality is homogeneous across different areas of the Seven Countries Study during 50-year follow-up. Acta Cardiol. 2017; [Aug 8]; [7 p.]. DOI:10.1080/00015385.2017.1351249
  • Menotti A, Kromhout D, Puddu PE, et al. Baseline fatty acids, food groups, a diet score and 50-year all-cause mortality rates. An ecological analysis of the Seven Countries Study. Ann Med. 2017;49:718–727.
  • Menotti A, Blackburn H, Kromhout D, et al. Changes in population cholesterol levels and coronary heart disease deaths in seven countries. Eur Heart J. 1997; 18:566–571.
  • Menotti A, Lanti M, Kafatos A, et al. The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Sudy. J Hypertens. 2004;22:1683–1690.
  • Lanti M, Menotti A, Nedeljkovic S, et al. Long-term trends in major cardiovascular risk factors in cohorts of aging men in the European cohorts of the Seven Countries Study. Aging Clin Exp Res. 2005; 17:306–315.
  • Menotti A, Lanti M, Kromhout D, et al. Forty-year coronary mortality trends and changes in major risk factors in the first 10 years of follow-up in the seven countries study. Eur J Epidemiol. 2007;22:747–754.
  • Schwartz CJ, Mitchell JR. The relation between myocardial lesions and coronary artery disease. i. An unselected necropsy study. Br Heart J. 1962;24:761–786.
  • Mitchell JR, Schwartz CJ. The relation between myocardial lesions and coronary artery disease ii. A selected group of patients with massive cardiac necrosis or scarring. Br Heart J. 1963;25:1–24.
  • Anonimous. Myocardial fibrosis. Br Med J. 1963; 1:1304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.